fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptika, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
insulin lilly humalog flacon injizierbare lösung
eli lilly (suisse) sa - insulinum lisprum - injizierbare lösung - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.5 mg. - diabetes mellitus - biotechnologika
insulin lilly humalog cartouches 3,0 ml injizierbare lösung
eli lilly (suisse) sa - insulinum lisprum - injizierbare lösung - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.5 mg. - diabetes mellitus - biotechnologika
insulin lilly humalog mix 25 cartouches 3,0 ml injizierbare suspension
eli lilly (suisse) sa - insulinum lisprum - injizierbare suspension - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg ut insulinum solutum 25 % et insulinum isophanum 75 %, protamini sulfas, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, phenolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 1 ml corresp. natrium 0.8 mg. - diabetes mellitus - biotechnologika
insulin lilly humalog mix 50 cartouches 3.0 ml injizierbare suspension
eli lilly (suisse) sa - insulinum lisprum - injizierbare suspension - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg ut insulinum solutum 50 % et insulinum isophanum 50 %, protamini sulfas, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, phenolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 1 ml corresp. natrium 0.8 mg. - diabetes mellitus - biotechnologika
lantus solution injectable en cartouche
sanofi-aventis (suisse) sa - insulinum glarginum - solution injectable en cartouche - insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika
apidra injizierbare lösung
sanofi-aventis (suisse) sa - insulinum glulisinum - injizierbare lösung - insulinum glulisinum 3.49 mg corresp. insulinum glulisinum 100 u., metacresolum, trometamolum, natrii chloridum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabilia q.s. ad solutionem pro 1 ml corresp. natrium 1.97 mg. - diabetes mellitus bei erwachsenen - biotechnologika
insulin lilly humalog 100 u.i./ml kwikpen stylo pré-remplies injizierbare lösung
eli lilly (suisse) sa - insulinum lisprum - injizierbare lösung - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.5 mg. - diabetes mellitus - biotechnologika
insulin lilly humalog 200 u.i./ml kwikpen stylo pré-remplies injizierbare lösung
eli lilly (suisse) sa - insulinum lisprum - injizierbare lösung - insulinum lisprum 200 u.i. corresp. insulinum lisprum 6.9 mg corresp. glycerolum, zinci oxidum, trometamolum, metacresolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.2 mg. - diabetes mellitus - biotechnologika
insulin lilly humalog mix 25 kwikpen seringues pré-remplies injizierbare suspension
eli lilly (suisse) sa - insulinum lisprum - injizierbare suspension - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg ut insulinum solutum 25 % et insulinum isophanum 75 %, protamini sulfas, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, phenolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 1 ml corresp. natrium 0.8 mg. - diabetes mellitus - biotechnologika